DuPont — Feb 11, 2025 release

“Our team’s ongoing focus on operational execution and cost discipline throughout 2024 delivered 100 basis points of margin expansion with 17% adjusted EPS growth for the full year, along with strong cash generation and related cash conversion of 105%.” “I am pleased with the progress we are making on the intended separation of our Electronics business targeted for November 1, 2025,” Koch added. “We also remain excited for and confident in DuPont’s value creation opportunities following the Electronics separation, centered around the high growth businesses of Water and Healthcare, along with other market-leading industrial product lines.” Fourth Quarter 2024 Consolidated Results (1) Dollars in millions, unless noted 4Q’24 4Q’23 Change vs. 4Q’23 Organic Sales (2) vs. 4Q’23 Net sales $3,092 $2,898 7% 7% GAAP Loss from continuing operations $(61) $(300) (80)% Operating EBITDA (2) $807 $715 13% Operating EBITDA margin (2) % 26.1  % 24.7  % 140 bps GAAP EPS from continuing operations $(0.17) $(0.72) (76)% Adjusted EPS (2) $1.13 $0.87 30% Cash provided by operating activities – cont. ops. $564 $646 (13)% Transaction-adjusted free cash flow (2) $455 $501 (9)% Net sales • Net sales and organic sales (2) increased 7% due to an 8% increase in volume, slightly offset by a 1% decrease in price. Higher volume was led by continued strong demand in electronics end-markets, a return to year-over-year growth in medical packaging and biopharma within healthcare markets, and further acceleration in water markets. (1) Results and cash flows are presented on a continuing operati